Evidence map›Paper›PMID 40045778›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2025

High-throughput approaches for the identification of ribosome heterogeneity.

Edwin S Kyei-Baffour, Qi Chang Lin, Ferhat Alkan, William J Faller

Abstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. RNA regulation in plants.Science China. Life sciences · 2026
    Review
  3. RiboScreenBiomedicines · 2026
    Review
  4. The ribosomal landscape in influenza A virus infection: from molecular mechanisms to clinical relevance.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edwin S Kyei-Baffour *Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.
Qi Chang Lin *Department of Neurology and Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.ORCID 0009-0005-6231-398X
Ferhat AlkanDivision of Oncogenomics, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.ORCID 0000-0001-6709-9605
William J FallerDivision of Oncogenomics, The Netherlands Cancer Institute, Amsterdam 1066CX, The Netherlands.ORCID 0000-0002-0738-2254

Funding

KWF KankerbestrijdingNederlandse Organisatie voor Wetenschappelijk Onderzoek
6 · The paper itself

Abstract

Recent advances in the fields of RNA translation and ribosome biology have demonstrated the heterogeneous nature of ribosomes. This manifests not only across different cellular contexts but also within the same cell. Such variations in ribosomal composition, be it in ribosomal RNAs or proteins, can significantly influence cellular processes and responses by altering the mRNAs being translated or the dynamics of ribosomes during the translation process. Therefore, identifying this heterogeneity is crucial for unravelling the complexity of gene expression across different fields of biology. Here we provide an overview of recent advances in high-throughput techniques for identifying ribosomal heterogeneity. We cover methodologies for probing both rRNA and protein components of the ribosome and encompass the most recent next-generation sequencing and computational analyses, as well as a diverse array of mass spectrometry techniques.This article is part of the discussion meeting issue 'Ribosome diversity and its impact on protein synthesis, development and disease'.

Indexed as

High-Throughput Nucleotide SequencingProtein BiosynthesisRibosomal ProteinsRibosomesRNA, RibosomalMass SpectrometryRibosomal ProteinsRNA, Ribosomalhigh-throughput techniquesribosomal proteinsribosome heterogeneityrRNA

Identifiers

PMID40045778
PMCPMC11883430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.